文献速递乳腺癌支持与姑息治疗

导管原位癌患者报告结局的系统综述

Patient-reported outcomes in ductal carcinoma in situ: A systematic review.
PubMed 文献 · Eur J Cancer · 2016-12-15

该系统综述检索五个电子数据库至2015年11月,纳入23篇文献报告17项研究,评估导管原位癌诊断和治疗后的患者报告结局。短期和长期比较不同治疗方案的证据缺乏;汇总证据显示生活质量核心方面和心理困扰在初期受显著影响,多数在术后6-12个月恢复至人群常模,全部在2年内恢复;复发和死于乳腺癌的恐惧被夸大且持续多年。

要点

  • 缺乏比较导管原位癌不同治疗方案短期和长期患者报告结局的证据。
  • 生活质量核心方面和心理困扰初期受显著影响,多数6-12个月恢复至人群常模,全部2年内恢复。
  • 复发和死于乳腺癌的恐惧被夸大,出现早且持续多年;性和身体意象影响通常较轻,术后1-3个月内缓解。

核心结论

  • 需要样本量充足的 patient-reported outcomes 研究来追踪康复轨迹及当代和新兴局部与全身治疗对导管原位癌的长期影响。
  • 患者报告结局数据可使医疗提供者为患者准备短期后遗症,并使有治疗选择权的患者能根据偏好选择治疗方案。

研究设计与样本

  • 系统综述,检索五个电子数据库(从建库至2015年11月),并交叉引用和联系专家。
  • 两位评价者独立应用纳入和质量标准并提取结果;筛选2130篇文献,23篇符合条件,报告17项研究。

主要发现

  • 缺乏比较导管原位癌不同治疗方案短期和长期患者报告结局的证据。
  • 汇总各治疗方案的证据显示生活质量核心方面(躯体、角色、社会、情绪功能、疼痛、疲乏)和心理困扰(焦虑、抑郁)初期受显著影响,多数方面在术后6-12个月恢复至人群常模,全部在术后2年内恢复。
  • 对复发和死于乳腺癌的恐惧被夸大,出现早且持续多年。
  • 性和身体意象影响通常较轻,术后1-3个月内缓解。
  • 少数女性经历相当大的影响,包括抑郁和与身体意象问题相关的性问题。

临床怎么用

  • 患者报告结局数据可使医疗提供者为患者准备短期后遗症。
  • 患者报告结局数据可使有治疗选择权的患者根据偏好选择治疗方案。

局限性

  • 缺乏比较导管原位癌不同治疗方案短期和长期患者报告结局的证据。
  • 需要样本量充足的 patient-reported outcomes 研究来追踪康复轨迹及长期影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ductal carcinoma in situ (DCIS) is a pre-invasive breast cancer with excellent prognosis but with potential adverse impacts of diagnosis and treatment on quality of life and other patient-reported outcomes (PROs). We undertook a systematic review to synthesise current evidence about PROs following diagnosis and treatment for DCIS. We searched five electronic databases (from database inception to November 2015), cross-referenced and contacted experts to identify studies that reported PROs after DCIS treatment. Two reviewers independently applied inclusion and quality criteria, and extracted findings. Of 2130 papers screened, 23 were eligible, reporting 17 studies. Short- and long-term PRO evidence about differences between DCIS treatment options was lacking. Evidence pooled across treatments indicated core aspects of quality of life (physical, role, social, emotional function, pain, fatigue) and psychological distress (anxiety, depression) were impacted significantly initially, with most aspects returning to population norms by 6-12 months, and all by 2 years post-operatively. Fears of recurrence and dying from breast cancer were exaggerated, occurred early and persisted for many years. Sexuality and body image impacts were generally low and resolved within 1-3 months after surgery. A minority of women experienced considerable impact, including depression and sexual issues associated with body image problems. Well-powered PRO studies are required to track recovery trajectories and long-term impacts of the range of contemporary and emerging local and systemic treatments for DCIS. PRO data would enable care providers to prepare patients for short-term sequelae and enable patients who have treatment options to exercise preferences in choosing among them.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. King MT, Winters ZE, Olivotto IA, et al. Patient-reported outcomes in ductal carcinoma in situ: A systematic review. Eur J Cancer. 2016. PMID: 27987454. doi:10.1016/j.ejca.2016.09.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。